Document o9669ZX5MJrxEXKEOpxB3jG2r

CHEMICAL MANUFACTURERS ASSOCIATION Vinyl Chloride Health Committee Record of Conference Call Date: Time: November 7,1994 9:30 a.m. List of Participants: Jim Barter Frank Hawk Jim Knaak Caffey Norman Jonathan Ramlow PPG Industries Borden Chemicals and Plastics Occidental Chemical Patton Boggs LLP Dow Chemical Has Shah CMA 1.0 The Committee reviewed the November 4 options paper prepared by Caffey Norman for addressing ATSDR/EPA test rule. The Committee agreed to work with ATSDR to address the data needs it initially identified. The Committee agreed with ATSDR's data need for a two-generation reproductive effects study. For the teratogenicity study, the Committee felt that the available data are adequate to meet the ATSDR needs. Jim Barter will prepare a draft position paper on the adequacy of the teratogenicity data to meet the ATSDR data needs. Mr. Norman will check with ATSDR officials to see if they would consider negotiating a voluntary testing program for vinyl chloride with industry. For the neurotoxicity data needs, Mr. Norman will follow-up with EPA's TSCA and Clean Air offices to clarify the Agency's rationale for the neurotoxicity study. 2.0 Jonathan Ramlow briefly discussed the brain cancer case control study of vinyl chloride workers proposed by Carlo Tamburo of the University of Louisville. Dr. Ramlow concluded that additional information from Dr. Tamburo is necessary to evaluate his proposal. Has Shah will invite Dr. Tamburo to the next Committee meeting to fully discuss his proposal. Subject To Approval Hasmukh C. Shah, Ph.D. Manager, Vinyl Chloride Panel CMA 022555